MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Drug Approval »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Administration Schedule < Drug Approval < Drug Carriers  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000638 (2018) Nicolai Leuchten [Allemagne] ; Martin Aringer [Allemagne]Tocilizumab in the treatment of giant cell arteritis.
000672 (2018) Ali Berkant Avci [Turquie] ; Eugen Feist [Allemagne] ; Gerd Rüdiger Burmester [Allemagne]Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference?
000908 (2018) Takayuki Yamamoto [États-Unis] ; Qi Li [République populaire de Chine] ; Hidetaka Hara [États-Unis] ; Liaoran Wang [République populaire de Chine] ; Hongmin Zhou [République populaire de Chine] ; Juan Li [République populaire de Chine] ; Devin E. Eckhoff [États-Unis] ; A. Joseph Tector [États-Unis] ; Edwin C. Klein [États-Unis] ; Ray Lovingood [États-Unis] ; Mohamed Ezzelarab [États-Unis] ; David Ayares [États-Unis] ; Yi Wang [République populaire de Chine] ; David K C. Cooper [États-Unis] ; Hayato Iwase [États-Unis]B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.
000909 (2018) Axicabtagene ciloleucel (Yescarta) for B-cell lymphoma.
000A16 (2017) Martin Sheppard [Royaume-Uni] ; Faidra Laskou [Royaume-Uni] ; Philip P. Stapleton [Royaume-Uni] ; Shahryar Hadavi [Royaume-Uni] ; Bhaskar Dasgupta [Royaume-Uni]Tocilizumab (Actemra).
000B60 (2017) Tetsuya Akaishi [Japon] ; Ichiro Nakashima [Japon]Efficiency of antibody therapy in demyelinating diseases.
000D90 (2016) M. Philippart [Pays-Bas] ; J. Schmidt [Suisse] ; B. Bittner [Suisse]Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens.
001172 (2015) David Ternant [France] ; Theodora Bejan-Angoulvant [France] ; Christophe Passot [France] ; Denis Mulleman [France] ; Gilles Paintaud [France]Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.
001573 (2013) Jeffrey R. Curtis [États-Unis] ; Fenglong Xie ; Rui Chen ; Lang Chen ; Meredith L. Kilgore ; James D. Lewis ; Huifeng Yun ; Jie Zhang ; Nicole C. Wright ; Elizabeth DelzellIdentifying newly approved medications in Medicare claims data: a case study using tocilizumab.
001985 (2010) Tocilizumab (Actemra) for rheumatoid arthritis.
001A29 (2010) Cheryl A. ThompsonFDA approves tocilizumab to treat rheumatoid arthritis.
001B28 (2008) Norihiro Nishimoto[IL-6 inhibitors for treatment of rheumatoid arthritis].
001B40 (2008) Yoshiyuki Ohsugi [Japon] ; Tadamitsu KishimotoThe recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis.
001D89 (????) Janice M. Reichert [États-Unis]Marketed therapeutic antibodies compendium.
001E09 (????) Janice M. ReichertLetter from the editor.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Drug Approval" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Drug Approval" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Drug Approval
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021